LumiraDx Financial Statements From 2010 to 2025
| LMDXDelisted Stock | USD 0.42 0.02 4.55% |
Check LumiraDx financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among LumiraDx's main balance sheet or income statement drivers, such as , as well as many indicators such as . LumiraDx financial statements analysis is a perfect complement when working with LumiraDx Valuation or Volatility modules.
LumiraDx |
LumiraDx Company Return On Asset Analysis
LumiraDx's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current LumiraDx Return On Asset | -0.28 |
Most of LumiraDx's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, LumiraDx is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
CompetitionBased on the latest financial disclosure, LumiraDx has a Return On Asset of -0.2804. This is 96.8% lower than that of the Biotechnology sector and 96.28% lower than that of the Health Care industry. The return on asset for all United States stocks is 100.29% higher than that of the company.
LumiraDx Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining LumiraDx's current stock value. Our valuation model uses many indicators to compare LumiraDx value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across LumiraDx competition to find correlations between indicators driving LumiraDx's intrinsic value. More Info.LumiraDx is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the LumiraDx's earnings, one of the primary drivers of an investment's value.About LumiraDx Financial Statements
LumiraDx investors use historical fundamental indicators, such as LumiraDx's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in LumiraDx. Please read more on our technical analysis and fundamental analysis pages.
LumiraDx Limited operates as a point of care diagnostics company. The company was founded in 2014 and is headquartered in London, the United Kingdom. Lumiradx is traded on NASDAQ Exchange in the United States.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Consideration for investing in LumiraDx Stock
If you are still planning to invest in LumiraDx check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the LumiraDx's history and understand the potential risks before investing.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |